688046 药康生物
已收盘 01-13 15:00:01
资讯
新帖
简况
药康生物（688046）披露关于参股公司回购公司所持股份暨关联交易的公告，1月7日股价上涨3.04%
证券之星 · 01-07
药康生物（688046）披露关于参股公司回购公司所持股份暨关联交易的公告，1月7日股价上涨3.04%
专职研发人员降至5人，百奥赛图估值靠什么支撑？
投资时报 · 2025-12-01
专职研发人员降至5人，百奥赛图估值靠什么支撑？
每周股票复盘：药康生物（688046）拟每10股派0.30元
证券之星 · 2025-11-16
每周股票复盘：药康生物（688046）拟每10股派0.30元
药康生物（688046）披露2025年半年度权益分派实施公告，11月13日股价上涨3.83%
证券之星 · 2025-11-13
药康生物（688046）披露2025年半年度权益分派实施公告，11月13日股价上涨3.83%
每周股票复盘：药康生物（688046）现561.75万元大宗交易
证券之星 · 2025-11-09
每周股票复盘：药康生物（688046）现561.75万元大宗交易
11月5日药康生物现561.75万元大宗交易
证券之星 · 2025-11-05
11月5日药康生物现561.75万元大宗交易
药康生物（688046）披露股份回购实施结果暨股份变动的公告，10月30日股价下跌0.69%
证券之星 · 2025-10-30
药康生物（688046）披露股份回购实施结果暨股份变动的公告，10月30日股价下跌0.69%
【机构调研记录】浙商基金调研优彩资源、药康生物等3只个股（附名单）
证券之星 · 2025-10-29
【机构调研记录】浙商基金调研优彩资源、药康生物等3只个股（附名单）
【机构调研记录】泰康基金调研药康生物、洁雅股份
证券之星 · 2025-10-29
【机构调研记录】泰康基金调研药康生物、洁雅股份
药康生物（688046）披露2025年员工持股计划预留份额非交易过户完成，10月28日股价下跌3.24%
证券之星 · 2025-10-28
药康生物（688046）披露2025年员工持股计划预留份额非交易过户完成，10月28日股价下跌3.24%
药康生物（688046）披露2025年三季度报告，10月22日股价上涨2.81%
证券之星 · 2025-10-22
药康生物（688046）披露2025年三季度报告，10月22日股价上涨2.81%
药康生物(688046.SH)发布前三季度业绩，归母净利润1.1亿元，同比增长11.9%
智通财经 · 2025-10-22
药康生物(688046.SH)发布前三季度业绩，归母净利润1.1亿元，同比增长11.9%
每周股票复盘：药康生物（688046）选举王韬为职工代表董事
证券之星 · 2025-10-19
每周股票复盘：药康生物（688046）选举王韬为职工代表董事
药康生物（688046）披露选举第二届董事会职工代表董事，10月13日股价下跌4.19%
证券之星 · 2025-10-13
药康生物（688046）披露选举第二届董事会职工代表董事，10月13日股价下跌4.19%
每周股票复盘：药康生物（688046）回购金额达2208.63万元
证券之星 · 2025-10-12
每周股票复盘：药康生物（688046）回购金额达2208.63万元
药康生物（688046）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌2.33%
证券之星 · 2025-10-09
药康生物（688046）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌2.33%
药康生物（688046）发布2025年员工持股计划预留份额分配方案，9月29日股价下跌4.13%
证券之星 · 2025-09-29
药康生物（688046）发布2025年员工持股计划预留份额分配方案，9月29日股价下跌4.13%
每周股票复盘：药康生物（688046）2025年第二次临时股东大会审议通过多项重要议案
证券之星 · 2025-09-28
每周股票复盘：药康生物（688046）2025年第二次临时股东大会审议通过多项重要议案
药康生物（688046）披露选举董事及修订公司章程等议案获股东大会通过，9月26日股价下跌3.56%
证券之星 · 2025-09-26
药康生物（688046）披露选举董事及修订公司章程等议案获股东大会通过，9月26日股价下跌3.56%
每周股票复盘：药康生物（688046）拟每10股派0.30元
证券之星 · 2025-09-21
每周股票复盘：药康生物（688046）拟每10股派0.30元
加载更多
公司概况
公司名称：
江苏集萃药康生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-04-25
主营业务：
江苏集萃药康生物科技股份有限公司的主营业务是实验动物模型的研发创制、生产销售及相关技术服务。公司的主要产品是商品化小鼠模型销售、模型定制、定制繁育、功能药效、全人源抗体转基因模型NeoMabTM及服务平台。
发行价格：
22.53
{"stockData":{"symbol":"688046","market":"SH","secType":"STK","nameCN":"药康生物","latestPrice":17.98,"timestamp":1768287601000,"preClose":17.85,"halted":0,"volume":6324334,"delay":0,"changeRate":0.0073,"floatShares":409999999,"shares":409999999,"eps":0.2964,"marketStatus":"已收盘","change":0.13,"latestTime":"01-13 15:00:01","open":17.8,"high":18.56,"low":17.73,"amount":115000000,"amplitude":0.0465,"askPrice":17.99,"askSize":25,"bidPrice":17.98,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.2964,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.85,"symbolType":"stock_kcb","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":19.64,"lowLimit":16.07,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":410000000,"isCdr":false,"pbRate":3.35,"roa":"--","peRate":60.661269,"roe":"5.05%","epsLYR":0.27,"committee":-0.769572,"marketValue":7372000000,"turnoverRate":0.0154,"status":0,"afterMarket":{"amount":0,"volume":0,"close":17.98,"buyVolume":0,"sellVolume":0,"time":1768289637558,"indexStatus":"已收盘 01-13 15:30:00","preClose":17.85},"floatMarketCap":7372000000},"requestUrl":"/m/hq/s/688046","defaultTab":"news","newsList":[{"id":"2601801801","title":"药康生物（688046）披露关于参股公司回购公司所持股份暨关联交易的公告，1月7日股价上涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601801801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601801801?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:26","pubTimestamp":1767795981,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，药康生物报收于16.94元，较前一交易日上涨3.04%，最新总市值为69.45亿元。近日，药康生物发布关于参股公司回购公司所持股份暨关联交易的公告。本次交易构成关联交易，已经公司董事会等相关会议审议通过，无需提交股东会审议，尚需各方完成内部审议程序后生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700038983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2588983779","title":"专职研发人员降至5人，百奥赛图估值靠什么支撑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2588983779","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588983779?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:18","pubTimestamp":1764602280,"startTime":"0","endTime":"0","summary":"创新药研发投入较大叠加三年净利润累计亏损近10亿元，百奥赛图资金压力加剧“基因编辑第一股”——百奥赛图（北京）医药科技股份有限公司（下称百奥赛图，2315.HK）距离实现“H+A”两地上市 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20251201/c672879464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["688046","BK0216","688265"],"gpt_icon":0},{"id":"2583651721","title":"每周股票复盘：药康生物（688046）拟每10股派0.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651721","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651721?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:08","pubTimestamp":1763237296,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，药康生物报收于18.38元，较上周的17.39元上涨5.69%。本周，药康生物11月14日盘中最高价报18.69元。本周关注点公司公告汇总：药康生物拟每10股派发现金红利0.30元（含税）。本次利润分配以扣除公司回购专用证券账户股份后的总股本408,970,000股为基数，合计派发现金红利12,269,100.00元（含税）。华泰联合证券对药康生物2025年半年度利润分配涉及的差异化分红事项出具核查意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2583913935","title":"药康生物（688046）披露2025年半年度权益分派实施公告，11月13日股价上涨3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583913935","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583913935?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:56","pubTimestamp":1763045779,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，药康生物报收于18.43元，较前一交易日上涨3.83%，最新总市值为75.56亿元。该股当日开盘17.79元，最高18.54元，最低17.66元，成交额达6215.18万元，换手率为0.83%。近日，药康生物发布2025年半年度权益分派实施公告，拟向全体股东每10股派发现金红利0.30元（含税），股权登记日为2025年11月19日，除权（息）日和现金红利发放日均为2025年11月20日。公司回购专用账户不参与分红，本次不送红股，不以资本公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300042829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2582864697","title":"每周股票复盘：药康生物（688046）现561.75万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864697?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:01","pubTimestamp":1762635676,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，药康生物（688046）报收于17.39元，较上周的17.82元下跌2.41%。本周，药康生物11月3日盘中最高价报19.09元。11月5日盘中最低价报17.37元。药康生物当前最新总市值71.3亿元，在医疗服务板块市值排名24/50，在两市A股市值排名2526/5166。本周关注点交易信息汇总：药康生物11月5日发生561.75万元大宗交易交易信息汇总11月5日药康生物现561.75万元大宗交易以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2581424457","title":"11月5日药康生物现561.75万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2581424457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581424457?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:29","pubTimestamp":1762334972,"startTime":"0","endTime":"0","summary":"近三个月该股共发生1笔大宗交易，合计成交3446.0手，折价成交1笔。该股近期无解禁股上市。截至2025年11月5日收盘，药康生物报收于17.92元，下跌0.72%，换手率0.85%，成交量3.48万手，成交额6174.07万元。该股最近90天内共有6家机构给出评级，买入评级3家，增持评级3家；过去90天内机构目标均价为20.89。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500029864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2579074119","title":"药康生物（688046）披露股份回购实施结果暨股份变动的公告，10月30日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579074119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579074119?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:21","pubTimestamp":1761819706,"startTime":"0","endTime":"0","summary":"公司近日发布公告，披露了关于股份回购实施结果暨股份变动的情况。公告显示，江苏集萃药康生物科技股份有限公司于2024年10月29日召开董事会，审议通过以集中竞价方式回购股份的方案，回购期限为2024年10月29日至2025年10月28日，拟回购金额为2,200万元至4,000万元，价格不超过18.00元/股，用于员工持股计划或股权激励。其中518,025股已用于2025年员工持股计划并完成非交易过户，其余股份存放于回购专用账户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000036589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2579914684","title":"【机构调研记录】浙商基金调研优彩资源、药康生物等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2579914684","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579914684?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:06","pubTimestamp":1761696393,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，浙商基金近期对3家上市公司进行了调研，相关名单如下：1）优彩资源 调研纪要：有机热载体锅炉改造项目采用生物质燃料替代天然气，预计年节约燃料成本2,354.90万元，减少总成本费用1,985.47万元，新增净利润1,499.39万元。浙商基金成立于2010年，截至目前，资产管理规模311.54亿元，排名103/210；资产管理规模220.67亿元，排名100/210；管理公募基金数72只，排名82/210；旗下公募基金经理14人，排名89/210。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900012542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002998","BK0216","688046","BK0208"],"gpt_icon":0},{"id":"2579642914","title":"【机构调研记录】泰康基金调研药康生物、洁雅股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2579642914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579642914?lang=zh_cn&edition=full","pubTime":"2025-10-29 08:06","pubTimestamp":1761696393,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月28日披露的机构调研信息，泰康基金近期对2家上市公司进行了调研，相关名单如下：1）药康生物 调研纪要：国内科研需求稳定，药企临床前投入恢复，工业客户收入向好；海外北美市场收入提速，未来仍将维持良好增速。灵康生物自Q2供应实验猪，预计2026年贡献利润。旗下最近一年表现最佳的公募基金产品为泰康研究精选股票发起A，最新单位净值为1.34，近一年增长77.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900012541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301108","BK0216","688046","BK0229"],"gpt_icon":0},{"id":"2578931730","title":"药康生物（688046）披露2025年员工持股计划预留份额非交易过户完成，10月28日股价下跌3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578931730","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578931730?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:56","pubTimestamp":1761645394,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，药康生物报收于17.0元，较前一交易日下跌3.24%，最新总市值为69.7亿元。公司于2025年10月28日发布公告称，其2025年员工持股计划的预留份额已完成非交易过户。截至公告披露日，员工持股计划证券账户持有公司股份2,040,000股，占公司总股本的0.50%。本员工持股计划存续期为36个月，自标的股票过户至持股计划名下之日起12个月且满足解锁条件后一次性解锁。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800033489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2577639370","title":"药康生物（688046）披露2025年三季度报告，10月22日股价上涨2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577639370","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577639370?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:21","pubTimestamp":1761142871,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，药康生物报收于17.18元，较前一交易日上涨2.81%，最新总市值为70.44亿元。该股当日开盘16.41元，最高17.2元，最低16.41元，成交额达6403.14万元，换手率为0.92%。近日，药康生物发布2025年第三季度报告。公告显示，公司2025年前三季度实现营业总收入575,576,818.48元，同比增长12.92%；归属于上市公司股东的净利润为109,900,074.60元，同比增长11.90%。截至2025年9月30日，公司总资产为2,830,055,938.71元，较上年度末增长10.01%；归属于上市公司股东的所有者权益为2,201,046,328.54元，较上年度末增长3.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200037582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2577357622","title":"药康生物(688046.SH)发布前三季度业绩，归母净利润1.1亿元，同比增长11.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577357622","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577357622?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:53","pubTimestamp":1761126805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药康生物(688046.SH)披露2025年第三季度报告，公司前三季度实现营收5.76亿元，同比增长12.92%;归属于上市公司股东的净利润1.1亿元，同比增长11.9%;扣非净利润9279万元，同比增长29.21%;基本每股收益0.27元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688046"],"gpt_icon":0},{"id":"2576449044","title":"每周股票复盘：药康生物（688046）选举王韬为职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2576449044","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576449044?lang=zh_cn&edition=full","pubTime":"2025-10-19 05:20","pubTimestamp":1760822425,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，药康生物报收于16.1元，较上周的17.18元下跌6.29%。本周，药康生物10月13日盘中最高价报16.76元。本周关注点公司公告汇总：药康生物选举王韬为第二届董事会职工代表董事，任期至本届董事会届满。王韬先生原为第二届董事会非独立董事，本次选举后变更为职工代表董事，任期自职工代表大会审议通过之日起至第二届董事会任期届满。兼任高级管理人员及职工代表董事人数未超过董事总数二分之一，符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2575471996","title":"药康生物（688046）披露选举第二届董事会职工代表董事，10月13日股价下跌4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575471996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575471996?lang=zh_cn&edition=full","pubTime":"2025-10-13 17:24","pubTimestamp":1760347463,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，药康生物报收于16.46元，较前一交易日下跌4.19%，最新总市值为67.49亿元。公司近日发布公告称，根据修订后的《公司章程》，董事会成员中应包括1名职工代表董事，由职工代表大会民主选举产生。王韬先生原为第二届董事会非独立董事，本次选举后变更为职工代表董事，任期自职工代表大会审议通过之日起至第二届董事会任期届满。兼任高级管理人员及职工代表董事人数未超过董事总数二分之一，符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300020119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2574683904","title":"每周股票复盘：药康生物（688046）回购金额达2208.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574683904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574683904?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:03","pubTimestamp":1760209394,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，药康生物报收于17.18元，较上周的18.06元下跌4.87%。本周，药康生物10月9日盘中最高价报18.37元。药康生物当前最新总市值70.44亿元，在医疗服务板块市值排名24/50，在两市A股市值排名2533/5158。本周关注点公司公告汇总：截至2025年9月30日，回购股份支付资金总额22,086,342.50元。公司公告汇总江苏集萃药康生物科技股份有限公司于2024年10月29日通过董事会决议，拟使用自有资金及专项贷款以集中竞价方式回购股份，用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2574291130","title":"药康生物（688046）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574291130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574291130?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:43","pubTimestamp":1760002998,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，药康生物报收于17.64元，较前一交易日下跌2.33%，最新总市值为72.32亿元。该股当日开盘18.37元，最高18.37元，最低17.52元，成交额达4314.67万元，换手率为0.59%。近日，药康生物发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，公司于2024年10月29日召开董事会，审议通过回购股份方案，拟使用自有资金及专项贷款以集中竞价方式回购股份，用于员工持股计划或股权激励。公司将持续履行信息披露义务，敬请投资者注意风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900023796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2571375813","title":"药康生物（688046）发布2025年员工持股计划预留份额分配方案，9月29日股价下跌4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571375813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571375813?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:38","pubTimestamp":1759156698,"startTime":"0","endTime":"0","summary":"近日，江苏集萃药康生物科技股份有限公司披露关于2025年员工持股计划预留份额确定购买价格及分配的公告。根据公告内容，公司于2025年9月29日召开员工持股计划管理委员会第一次会议，审议通过预留份额购买价格及分配方案。本次预留份额向不超过12名核心骨干员工授予，合计327.52万份，对应标的股票46.00万股，占员工持股计划总份额的22.55%。持股计划所获股票自2025年6月5日过户至员工持股计划账户起12个月后一次性解锁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2570689443","title":"每周股票复盘：药康生物（688046）2025年第二次临时股东大会审议通过多项重要议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2570689443","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570689443?lang=zh_cn&edition=full","pubTime":"2025-09-28 04:00","pubTimestamp":1759003245,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，药康生物报收于18.42元，较上周的18.57元下跌0.81%。本周关注点公司公告汇总：药康生物2025年第二次临时股东大会审议通过利润分配预案、取消监事会并修订公司章程等议案。公司公告汇总江苏集萃药康生物科技股份有限公司于2025年9月25日召开2025年第二次临时股东大会，会议由董事会召集，董事长高翔主持，采取现场与网络投票相结合方式举行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800001014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2570009814","title":"药康生物（688046）披露选举董事及修订公司章程等议案获股东大会通过，9月26日股价下跌3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009814","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570009814?lang=zh_cn&edition=full","pubTime":"2025-09-26 17:27","pubTimestamp":1758878843,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，药康生物报收于18.42元，较前一交易日下跌3.56%，最新总市值为75.52亿元。根据公司近日发布的公告，江苏集萃药康生物科技股份有限公司于2025年9月25日召开2025年第二次临时股东大会，出席会议的股东及代理人共60人，代表表决权股份264,824,992股，占公司总股本的64.8270%。其中，取消监事会及修订章程为特别决议议案，已获出席股东所持表决权三分之二以上通过。所有议案均未涉及关联股东回避表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600027938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2569246504","title":"每周股票复盘：药康生物（688046）拟每10股派0.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246504","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246504?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:09","pubTimestamp":1758398953,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，药康生物报收于18.57元，较上周的18.4元上涨0.92%。本周，药康生物9月16日盘中最高价报20.5元，股价触及近一年最高点。本周关注点公司公告汇总：药康生物拟向全体股东每10股派发现金红利0.30元（含税）。公司公告汇总药康生物2025年第二次临时股东大会会议资料江苏集萃药康生物科技股份有限公司召开2025年第二次临时股东大会，审议四项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688046"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768299761432,"stockEarnings":[{"period":"1week","weight":0.0871},{"period":"1month","weight":0.1276},{"period":"3month","weight":0.1224},{"period":"6month","weight":0.223},{"period":"1year","weight":0.4196},{"period":"ytd","weight":0.1621}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏集萃药康生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6658人(较上一季度减少7.69%)","perCapita":"61580股","listingDate":"2022-04-25","address":"江苏省南京市浦口区江北新区学府路12号","registeredCapital":"41000万元","survey":" 江苏集萃药康生物科技股份有限公司的主营业务是实验动物模型的研发创制、生产销售及相关技术服务。公司的主要产品是商品化小鼠模型销售、模型定制、定制繁育、功能药效、全人源抗体转基因模型NeoMabTM及服务平台。","listedPrice":22.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药康生物,688046,药康生物股票,药康生物股票老虎,药康生物股票老虎国际,药康生物行情,药康生物股票行情,药康生物股价,药康生物股市,药康生物股票价格,药康生物股票交易,药康生物股票购买,药康生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}